Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells
Molecules · 25.11.2023 · 28 (23) · 7777
DOI: 10.3390/molecules28237777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 25.11.2023. Verfasst von Elif Merve Aydin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Koç University Research Center for Translational Medicine (KUTTAM), Istanbul 34450, Turkey. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Chalcone, Chalcones, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian cancer ranks as the eighth most prevalent form of cancer in women across the globe and stands as the third most frequent gynecological cancer, following cervical and endometrial cancers. Given its resistance to standard chemotherapy and high recurrence rates, there is an urgent imperative to discover novel compounds with potential as chemotherapeutic agents for treating ovarian cancer. Chalcones exhibit a wide array of biological properties, with a particular focus on their anti-cancer activities. In this research, we documented the synthesis and in vitro study of a small library of chalcone derivatives designed for use against high-grade serous ovarian cancer (HGSOC) cell lines, specifically OVCAR-3, OVSAHO, and KURAMOCHI. Our findings revealed that three of these compounds exhibited cytotoxic and anti-proliferative effects against all the tested HGSOC cell lines, achieving IC50 concentrations lower than 25 µM. Further investigations disclosed that these chalcones prompted an increase in the subG1 phase cell cycle and induced apoptosis in OVCAR-3 cells. In summary, our study underscores the potential of chalcones as promising agents for the treatment of ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Koç University Research Center for Translational Medicine (KUTTAM), Istanbul 34450, Turkey.
- Dipartimento di Chimica, Università degli Studi di Milano, 20133 Milano, Italy.
- Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
- School of Medicine, Koç University, Istanbul 34450, Turkey.
ORCID-Profile: Elif Merve Aydin, İdil Su Canıtez, Eleonora Colombo, Salvatore Princiotto, Daniele Passarella, Sabrina Dallavalle, Michael S Christodoulou, Irem Durmaz Şahin
Zitieren
APA
Merve Aydin, E., Canıtez, İ. S., Colombo, E., Princiotto, S., Passarella, D., Dallavalle, S., Christodoulou, M. S., & Durmaz Şahin, I. (2023). Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells. Molecules, 28(23), 7777. https://doi.org/10.3390/molecules28237777
Vancouver
Merve Aydin E, Canıtez İS, Colombo E, Princiotto S, Passarella D, Dallavalle S, et al. Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells. Molecules. 2023;28(23):7777. doi:10.3390/molecules28237777
BibTeX
@article{MerveAydin2023,
author = {Merve Aydin, Elif and Canıtez, İdil Su and Colombo, Eleonora and Princiotto, Salvatore and Passarella, Daniele and Dallavalle, Sabrina and Christodoulou, Michael S and Durmaz Şahin, Irem},
title = {Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells},
journal = {Molecules},
year = {2023},
volume = {28},
number = {23},
pages = {7777},
doi = {10.3390/molecules28237777}
}
EUVIMED